Vault-13

PSP Research LLC

LAS VEGAS, NV · CIK 2106939 · 13F filing filed 2026-07-09

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$187.9m reported value +32.9% vs Q1 2026
75positions
88.0%in top 10
11 new 1 added 30 reduced 15 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SPDR SER TR S&P BIOTECH XBI XBI 570,000 $90.2m48.01% 48.01% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 284.9k, Q2 2026 570.0k +285.1k +285,100 100.1%
2 ISHARES TR 0-3 MNTH TREASRY SGOV SGOV 700,000 $70.5m37.51% 37.51% UnchangedShares held: Q3 2025 —, Q4 2025 700.0k, Q1 2026 700.0k, Q2 2026 700.0k
3 ROYALTY PHARMA PLC SHS CLASS A RPRX RPRX 11,000 $616.8k0.33% 0.33% UnchangedShares held: Q3 2025 —, Q4 2025 13.8k, Q1 2026 11.0k, Q2 2026 11.0k
4 NURIX THERAPEUTICS INC COM NRIX NRIX 25,000 $606.5k0.32% 0.32% ReducedShares held: Q3 2025 —, Q4 2025 28.7k, Q1 2026 28.7k, Q2 2026 25.0k -3.7k -3,700 -12.9%
5 INCYTE CORP COM INCY INCY 5,300 $600.8k0.32% 0.32% UnchangedShares held: Q3 2025 —, Q4 2025 5.3k, Q1 2026 5.3k, Q2 2026 5.3k
6 ARGENX SE SPONSORED ADR ARGX ARGX 641 $594.7k0.32% 0.32% UnchangedShares held: Q3 2025 —, Q4 2025 630, Q1 2026 641, Q2 2026 641
7 DISC MEDICINE INC COM IRON IRON 8,000 $585.1k0.31% 0.31% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 8.0k, Q2 2026 8.0k
8 RAPPORT THERAPEUTICS INC COM RAPP RAPP 14,000 $583.4k0.31% 0.31% UnchangedShares held: Q3 2025 —, Q4 2025 17.5k, Q1 2026 14.0k, Q2 2026 14.0k
9 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 17,000 $567.6k0.30% 0.30% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 22.1k, Q2 2026 17.0k -5.1k -5,100 -23.1%
10 TREVI THERAPEUTICS INC COM TRVI TRVI 30,000 $559.5k0.30% 0.30% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 30.0k, Q2 2026 30.0k
11 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 23,000 $556.6k0.30% 0.30% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 28.0k, Q2 2026 23.0k -5.0k -5,000 -17.9%
12 TG THERAPEUTICS INC COM TGTX TGTX 10,000 $549.4k0.29% 0.29% ReducedShares held: Q3 2025 —, Q4 2025 17.8k, Q1 2026 13.0k, Q2 2026 10.0k -3.0k -3,000 -23.1%
13 HALOZYME THERAPEUTICS INC COM HALO HALO 7,000 $547.9k0.29% 0.29% ReducedShares held: Q3 2025 —, Q4 2025 8.0k, Q1 2026 8.0k, Q2 2026 7.0k -1.0k -1,026 -12.8%
14 IONIS PHARMACEUTICALS INC COM IONS IONS 6,800 $539.2k0.29% 0.29% UnchangedShares held: Q3 2025 —, Q4 2025 6.8k, Q1 2026 6.8k, Q2 2026 6.8k
15 PHARVARIS N V COM PHVS PHVS 15,000 $518.7k0.28% 0.28% ReducedShares held: Q3 2025 —, Q4 2025 20.5k, Q1 2026 20.0k, Q2 2026 15.0k -5.0k -5,000 -25.0%
16 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 19,700 $516.5k0.27% 0.27% UnchangedShares held: Q3 2025 —, Q4 2025 18.7k, Q1 2026 19.7k, Q2 2026 19.7k
17 AURINIA PHARMACEUTICALS INC COM AUPH AUPH 30,000 $509.1k0.27% 0.27% UnchangedShares held: Q3 2025 —, Q4 2025 34.0k, Q1 2026 30.0k, Q2 2026 30.0k
18 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 3,000 $505.6k0.27% 0.27% ReducedShares held: Q3 2025 —, Q4 2025 3.7k, Q1 2026 3.8k, Q2 2026 3.0k -848 -848 -22.0%
19 IMMUNOVANT INC COM IMVT IMVT 13,000 $500.9k0.27% 0.27% ReducedShares held: Q3 2025 —, Q4 2025 20.3k, Q1 2026 19.2k, Q2 2026 13.0k -6.2k -6,200 -32.3%
20 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 19,766 $500.1k0.27% 0.27% UnchangedShares held: Q3 2025 —, Q4 2025 19.8k, Q1 2026 19.8k, Q2 2026 19.8k
21 PTC THERAPEUTICS INC COM PTCT PTCT 6,000 $489.4k0.26% 0.26% UnchangedShares held: Q3 2025 —, Q4 2025 7.0k, Q1 2026 6.0k, Q2 2026 6.0k
22 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 13,000 $483.7k0.26% 0.26% UnchangedShares held: Q3 2025 —, Q4 2025 20.4k, Q1 2026 13.0k, Q2 2026 13.0k
23 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 15,141 $480.7k0.26% 0.26% UnchangedShares held: Q3 2025 —, Q4 2025 14.4k, Q1 2026 15.1k, Q2 2026 15.1k
24 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 10,000 $470.4k0.25% 0.25% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 34.8k, Q2 2026 10.0k -24.8k -24,800 -71.3%
25 COGENT BIOSCIENCES INC COM COGT COGT 12,000 $464.4k0.25% 0.25% UnchangedShares held: Q3 2025 —, Q4 2025 13.2k, Q1 2026 12.0k, Q2 2026 12.0k
26 KYMERA THERAPEUTICS INC COM KYMR KYMR 4,000 $458.7k0.24% 0.24% ReducedShares held: Q3 2025 —, Q4 2025 6.3k, Q1 2026 6.3k, Q2 2026 4.0k -2.3k -2,300 -36.5%
27 DYNE THERAPEUTICS INC COM DYN DYN 20,000 $444.2k0.24% 0.24% UnchangedShares held: Q3 2025 —, Q4 2025 21.5k, Q1 2026 20.0k, Q2 2026 20.0k
28 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 1,465 $441.0k0.23% 0.23% UnchangedShares held: Q3 2025 —, Q4 2025 1.3k, Q1 2026 1.5k, Q2 2026 1.5k
29 TARSUS PHARMACEUTICALS INC COM TARS TARS 7,000 $440.6k0.23% 0.23% UnchangedShares held: Q3 2025 —, Q4 2025 6.5k, Q1 2026 7.0k, Q2 2026 7.0k
30 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 20,000 $437.2k0.23% 0.23% UnchangedShares held: Q3 2025 —, Q4 2025 24.7k, Q1 2026 20.0k, Q2 2026 20.0k
31 EXELIXIS INC COM EXEL EXEL 8,000 $435.3k0.23% 0.23% ReducedShares held: Q3 2025 —, Q4 2025 11.9k, Q1 2026 11.9k, Q2 2026 8.0k -3.9k -3,948 -33.0%
32 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 11,000 $411.6k0.22% 0.22% UnchangedShares held: Q3 2025 —, Q4 2025 11.3k, Q1 2026 11.0k, Q2 2026 11.0k
33 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 12,000 $406.7k0.22% 0.22% ReducedShares held: Q3 2025 —, Q4 2025 14.9k, Q1 2026 15.0k, Q2 2026 12.0k -3.0k -3,000 -20.0%
34 ASCENDIS PHARMA A/S ORD SHS ASND ASND 1,500 $400.1k0.21% 0.21% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 1.5k
35 LIQUIDIA CORPORATION COM NEW LQDA LQDA 5,000 $398.6k0.21% 0.21% NewShares held: Q3 2025 —, Q4 2025 15.5k, Q1 2026 0, Q2 2026 5.0k
36 STOKE THERAPEUTICS INC COM STOK STOK 12,000 $392.6k0.21% 0.21% UnchangedShares held: Q3 2025 —, Q4 2025 16.6k, Q1 2026 12.0k, Q2 2026 12.0k
37 VIKING THERAPEUTICS INC COM VKTX VKTX 10,000 $390.1k0.21% 0.21% ReducedShares held: Q3 2025 —, Q4 2025 14.7k, Q1 2026 15.0k, Q2 2026 10.0k -5.0k -5,000 -33.3%
38 IMMUNOME INC COM IMNM IMNM 18,000 $381.4k0.20% 0.20% ReducedShares held: Q3 2025 —, Q4 2025 25.2k, Q1 2026 20.0k, Q2 2026 18.0k -2.0k -2,000 -10.0%
39 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 3,000 $367.7k0.20% 0.20% UnchangedShares held: Q3 2025 —, Q4 2025 6.1k, Q1 2026 3.0k, Q2 2026 3.0k
40 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 10,000 $364.1k0.19% 0.19% ReducedShares held: Q3 2025 —, Q4 2025 14.3k, Q1 2026 14.3k, Q2 2026 10.0k -4.3k -4,283 -30.0%
41 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 7,000 $355.2k0.19% 0.19% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 7.0k, Q2 2026 7.0k
42 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 4,000 $355.1k0.19% 0.19% ReducedShares held: Q3 2025 —, Q4 2025 15.8k, Q1 2026 5.2k, Q2 2026 4.0k -1.2k -1,159 -22.5%
43 INTELLIA THERAPEUTICS INC COM NTLA NTLA 20,000 $338.4k0.18% 0.18% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 26.9k, Q2 2026 20.0k -6.9k -6,900 -25.6%
44 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 600 $322.2k0.17% 0.17% UnchangedShares held: Q3 2025 —, Q4 2025 892, Q1 2026 600, Q2 2026 600
45 KINIKSA PHARMACEUTICALS INTL ORD SHS CL A KNSA KNSA 5,000 $319.8k0.17% 0.17% ReducedShares held: Q3 2025 —, Q4 2025 12.7k, Q1 2026 9.0k, Q2 2026 5.0k -4.0k -4,000 -44.4%
46 ALKERMES PLC SHS ALKS ALKS 6,000 $314.4k0.17% 0.17% UnchangedShares held: Q3 2025 —, Q4 2025 19.3k, Q1 2026 6.0k, Q2 2026 6.0k
47 TANGO THERAPEUTICS INC COM TNGX TNGX 10,000 $312.6k0.17% 0.17% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 14.4k, Q2 2026 10.0k -4.4k -4,400 -30.6%
48 ARDELYX INC COM ARDX ARDX 60,000 $306.0k0.16% 0.16% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 80.0k, Q2 2026 60.0k -20.0k -20,000 -25.0%
49 VERA THERAPEUTICS INC CL A VERA VERA 7,000 $300.4k0.16% 0.16% ReducedShares held: Q3 2025 —, Q4 2025 10.0k, Q1 2026 10.0k, Q2 2026 7.0k -3.0k -3,000 -30.0%
50 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 2,500 $292.7k0.16% 0.16% ReducedShares held: Q3 2025 —, Q4 2025 6.9k, Q1 2026 5.0k, Q2 2026 2.5k -2.5k -2,500 -50.0%
51 ORUKA THERAPEUTICS INC COM ORKA ORKA 3,000 $285.5k0.15% 0.15% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 5.0k, Q2 2026 3.0k -2.0k -1,968 -39.6%
52 SUPERNUS PHARMACEUTICALS INC COM SUPN SUPN 6,000 $279.1k0.15% 0.15% UnchangedShares held: Q3 2025 —, Q4 2025 10.8k, Q1 2026 6.0k, Q2 2026 6.0k
53 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 5,000 $272.7k0.15% 0.15% ReducedShares held: Q3 2025 —, Q4 2025 9.6k, Q1 2026 9.5k, Q2 2026 5.0k -4.5k -4,500 -47.4%
54 ZYMEWORKS INC COM ZYME ZYME 10,000 $261.4k0.14% 0.14% UnchangedShares held: Q3 2025 —, Q4 2025 20.3k, Q1 2026 10.0k, Q2 2026 10.0k
55 KRYSTAL BIOTECH INC COM KRYS KRYS 692 $257.2k0.14% 0.14% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 692
56 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 18,000 $254.7k0.14% 0.14% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 71.0k, Q2 2026 18.0k -53.0k -53,000 -74.7%
57 XENON PHARMACEUTICALS INC COM XENE XENE 4,200 $253.5k0.13% 0.13% UnchangedShares held: Q3 2025 —, Q4 2025 11.7k, Q1 2026 4.2k, Q2 2026 4.2k
58 AXSOME THERAPEUTICS INC COM AXSM AXSM 1,000 $244.8k0.13% 0.13% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 2.8k, Q2 2026 1.0k -1.8k -1,845 -64.8%
59 ARRIVENT BIOPHARMA INC COM AVBP AVBP 7,041 $244.6k0.13% 0.13% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 7.0k
60 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 2,500 $243.7k0.13% 0.13% ReducedShares held: Q3 2025 —, Q4 2025 12.7k, Q1 2026 5.0k, Q2 2026 2.5k -2.5k -2,500 -50.0%
61 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 971 $234.0k0.12% 0.12% NewShares held: Q3 2025 —, Q4 2025 3.3k, Q1 2026 0, Q2 2026 971
62 KODIAK SCIENCES INC COM KOD KOD 6,000 $233.8k0.12% 0.12% ReducedShares held: Q3 2025 —, Q4 2025 19.4k, Q1 2026 10.0k, Q2 2026 6.0k -4.0k -4,000 -40.0%
63 REVOLUTION MEDICINES INC COM RVMD RVMD 1,200 $224.7k0.12% 0.12% NewShares held: Q3 2025 —, Q4 2025 6.9k, Q1 2026 0, Q2 2026 1.2k
64 BRIDGEBIO PHARMA INC COM BBIO BBIO 3,000 $223.4k0.12% 0.12% ReducedShares held: Q3 2025 —, Q4 2025 7.1k, Q1 2026 6.0k, Q2 2026 3.0k -3.0k -3,000 -50.0%
65 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 2,000 $222.1k0.12% 0.12% NewShares held: Q3 2025 —, Q4 2025 4.7k, Q1 2026 0, Q2 2026 2.0k
66 DENALI THERAPEUTICS INC COM DNLI DNLI 8,463 $217.7k0.12% 0.12% NewShares held: Q3 2025 —, Q4 2025 31.8k, Q1 2026 0, Q2 2026 8.5k
67 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 2,600 $211.9k0.11% 0.11% NewShares held: Q3 2025 —, Q4 2025 6.7k, Q1 2026 0, Q2 2026 2.6k
68 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 3,827 $210.5k0.11% 0.11% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 3.8k
69 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 5,000 $203.2k0.11% 0.11% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 6.5k, Q2 2026 5.0k -1.5k -1,500 -23.1%
70 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 10,838 $194.7k0.10% 0.10% UnchangedShares held: Q3 2025 —, Q4 2025 44.2k, Q1 2026 10.8k, Q2 2026 10.8k
71 CYTOMX THERAPEUTICS INC COM CTMX CTMX 39,400 $147.8k0.08% 0.08% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 39.4k
72 OCULAR THERAPEUTIX INC COM OCUL OCUL 15,000 $147.3k0.08% 0.08% UnchangedShares held: Q3 2025 —, Q4 2025 42.9k, Q1 2026 15.0k, Q2 2026 15.0k
73 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 10,000 $143.0k0.08% 0.08% UnchangedShares held: Q3 2025 —, Q4 2025 29.5k, Q1 2026 10.0k, Q2 2026 10.0k
74 ORIC PHARMACEUTICALS INC COM ORIC ORIC 13,000 $140.8k0.07% 0.07% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 13.0k, Q2 2026 13.0k
75 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 10,000 $125.1k0.07% 0.07% UnchangedShares held: Q3 2025 —, Q4 2025 19.1k, Q1 2026 10.0k, Q2 2026 10.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
SERA PROGNOSTICS INC SERA SERA 2,396,685 $4.9m2.4m shares
TYRA BIOSCIENCES INC TYRA TYRA 16,000 $612.8k16.0k shares
ASCENDIS PHARMA A/S 2,500 $571.8k2.5k shares
CYTOKINETICS INC CYTK CYTK 8,300 $547.1k8.3k shares
AGIOS PHARMACEUTICALS INC AGIO AGIO 15,000 $507.4k15.0k shares
PRAXIS PRECISION MEDICINES I PRAX PRAX 1,500 $483.3k1.5k shares
INHIBRX BIOSCIENCES INC INBX INBX 6,927 $465.7k6.9k shares
ERASCA INC ERAS ERAS 17,327 $280.4k17.3k shares
CELCUITY INC CELC CELC 2,000 $228.3k2.0k shares
KALVISTA PHARMACEUTICALS INC KALV KALV 10,795 $217.3k10.8k shares
LEGEND BIOTECH CORP LEGN LEGN 12,000 $217.1k12.0k shares
APOGEE THERAPEUTICS INC 2,500 $210.4k2.5k shares
UNITED THERAPEUTICS CORP DEL UTHR UTHR 350 $207.5k350 shares
SUMMIT THERAPEUTICS INC SMMT SMMT 10,223 $193.8k10.2k shares
COMPASS THERAPEUTICS INC CMPX CMPX 30,000 $158.7k30.0k shares